Digital
29th - 30th October 2020

4th Annual MarketsandMarkets Bioprocessing of Advanced Cellular Therapies Congress-VIRTUAL (Time Zone -GREENWHICH MEAN TIME (GMT))

20+
Speakers
100+
Attendees
6
Networking Hours
4+
Sessions

Devising the effective manufacturing and quality control methods of cell therapies

Regenerative therapies are proving its acceptance in potential of cell-based therapies for chronic disorders. Since our past three editions, our aim through this conference is to provide illustrative approach to recent developments in technologies of bioprocessing of cellular therapies, to process development and addressing qualitative and regulatory hurdles.

In the 4th edition of MarketsandMarkets Bioprocessing of Advanced Cellular Therapies Congress-VIRTUAL, we would be focusing on the manufacturing, process development, regulatory aspects of cell therapies and gene therapies. The special impact would be laid on, gene delivery based therapies, car-T cell-based immunotherapies, automated manufacturing, allogenic therapies, with the aspects of hurdles in supply chain management and regulatory affairs.

Click here to view the post show report for the 2nd Annual MarketsandMarkets Cell-Gene therapy Bioprocessing Online Conference 

 

WHAT TO EXPECT

Key Highlights

• Stem cell transplantation for cellular aspects
• Culture technology for cell & Gene therapy applications
• Ex-vivo cell and gene therapy manufacturing
• Autologous gene therapy delivery
• Conventional Car-T cell delivery
• Allogenic Car-T cell therapy application
• Quality control in manufacturing of cell therapy
• Supply chain management for cell therapy management
• Regulatory and reimbursement issues based on GMP guidelines

Who should attend?

  • Vice Presidents
  • Directors
  • Managers
  • Heads
  • Leaders
  • Engineers
  • Scientists
  • Professors 
  • Researchers
  • Project leaders

Departments

  • Cell Culture
  • Cell Therapy
  • Upstream Processing
  • Stem Cell therapy
  • Process Development
  • Bioprocessing
  • Downstream Processing
  • Quality Control
  • Bioengineering
  • Translational Sciences
  • Scale-up/out
  • Bioprocess development
  • Quality Control
  • Biotherapeutics
  • Cell Engineering
  • Regulatory affairs

CONFERENCE AGENDA
ANALYTICS AND QUALITY CONTROL FOR CELL AND GENE THERAPY PRODUCTS
LOGISTICS, REGULATORY & INVESTMENT
CONFERENCE SPEAKERS
Advisors
Petter Bjorquist
Petter Bjorquist
CEO, Verigraft
Speakers
Tristan Pritchard-Meaker
Tristan Pritchard-Meaker
, Leiden University Medical Centre
Kevin Jackson
Kevin Jackson
Technical Director, Wyatt Technology, UK
Steve Swioklo
Steve Swioklo
CSO and Co-founder, Atelerix Ltd
Ivan Wall
Ivan Wall
Professor of Regenerative Medicine, Cell & Gene Therapy Bioprocessing, Aston University
Christoph Herwig
Christoph Herwig
Bioprocess development & facility design, Werum IT Solutions
Fiona Bellot
Fiona Bellot
Protein Sales Manager, Proteintech Group
Roystein Bulman
Roystein Bulman
European Applications Manager, Nova Biomedical
Ohad Karneili
Ohad Karneili
Founder & CEO, Adva Biotechnology
SPONSORS
Gold
example-image

Nexcelom Bioscience

example-image

Malvern Panalytical

Silver
example-image

NovaBiomedical

Speaking Partner
example-image

Boyds

example-image

RoslinCT

example-image

Alphalyse

example-image

Proteintech Group

example-image

Atelerix Ltd

example-image

K0RBER PHARMA SOFTWARE, WERUM IT SOLUTIONS GMBH

example-image

Wyatt Technology UK Ltd

Exhibition Partner
example-image

Sartorius Stedim Biotech GmbH

example-image

BioIVT

PARTNERS
Supporting Association
MabDesign

MabDesign

RegMedNet

RegMedNet

Irish Stem Cell Foundation

Irish Stem Cell Foundation

UKSB

UKSB

Media Partners
example-image

Technology Networks

example-image

GEN

example-image

Drug Target Review

example-image

CrowdReviews.com

example-image

Medical events guide

PAST EVENT GALLERY